0 NASDAQ Companies - October 11, 2024Royalty Pharma Declares Fourth Quarter 2024 DividendNEW YORK, Oct. 11, 2024 (GLOBE NEWSWIRE) — The board of directors of Royalty Pharma plc (Nasdaq: RPRX) has approved […]Read More
0 NASDAQ Companies - October 11, 202423andMe Announces 1-for-20 Reverse Stock SplitSUNNYVALE, Calif., Oct. 11, 2024 (GLOBE NEWSWIRE) — 23andMe Holding Co. (Nasdaq: ME) (the “Company” or “23andMe”), announced today that […]Read More
0 NASDAQ Companies - October 11, 2024MaxCyte to Report Third Quarter 2024 Financial Results on November 6, 2024ROCKVILLE, Md., Oct. 11, 2024 (GLOBE NEWSWIRE) — MaxCyte, Inc., (NASDAQ: MXCT; LSE: MXCT), a leading, cell-engineering focused company providing […]Read More
0 NASDAQ Companies - October 11, 2024Alignment Healthcare Continues to Deliver High-Quality Medicare Advantage Plans, 4 Stars or Greater for 98% of Members in 2025ORANGE, Calif., Oct. 11, 2024 (GLOBE NEWSWIRE) — Alignment Healthcare, Inc. (NASDAQ: ALHC) announced today that 98% of its Alignment […]Read More
0 NASDAQ Companies - October 11, 2024Paltalk Holdings Announces Judge Enters Final Judgment in Connection With Cisco Jury VerdictJERICHO, N.Y. , Oct. 11, 2024 (GLOBE NEWSWIRE) — Paltalk, Inc. (“Paltalk,” the “Company,” “we,” our,” or “us”) (NASDAQ: PALT), […]Read More
0 NASDAQ Companies - October 11, 2024Alterity Therapeutics Announces Presentation of New Data Describing Neuroprotection of ATH434 at Neuroscience MeetingMELBOURNE, Australia and SAN FRANCISCO, Oct. 11, 2024 (GLOBE NEWSWIRE) — Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the […]Read More
0 NASDAQ Companies - October 11, 2024Tourmaline Bio to Showcase Two Poster Presentations at the 2024 Cardiometabolic Health CongressNEW YORK, Oct. 11, 2024 (GLOBE NEWSWIRE) — Tourmaline Bio, Inc. (Tourmaline) (NASDAQ: TRML), a late-stage clinical biotechnology company developing […]Read More
0 NASDAQ Companies - October 11, 2024Balchem Corporation Announces Quarterly Conference Call for Third Quarter Financial Results on October 25, 2024MONTVALE, N.J., Oct. 11, 2024 (GLOBE NEWSWIRE) — Balchem Corporation (NASDAQ: BCPC) today announced that a conference call will be […]Read More
0 NASDAQ Companies - October 11, 2024Sagimet Biosciences Announces Publication of Results from Phase 2b FASCINATE-2 Clinical Trial of Denifanstat in Biopsy-Confirmed F2/F3 MASH in The Lancet Gastroenterology & Hepatology– Treatment with denifanstat achieved statistically significant and clinically meaningful improvements in disease activity, MASH resolution and fibrosis –– Results […]Read More
0 NASDAQ Companies - October 11, 2024AGBA ADVANCES TOWARD COMPLETION OF THE TRILLER MERGERAGBA Group Holding Limited (Nasdaq: AGBA) (“AGBA” or the “Company”) and Triller Corp. (“Triller”), today announced that their merger is […]Read More